StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1030
This month
15
This week
6
This year
106
Today
1
Yesterday
1
Publishing Date
2024 - 04 - 22
5
2024 - 03 - 25
4
2024 - 03 - 22
5
2024 - 02 - 28
5
2024 - 02 - 15
4
2024 - 02 - 12
4
2023 - 12 - 12
4
2023 - 12 - 05
4
2023 - 09 - 25
4
2023 - 09 - 18
5
2023 - 07 - 27
6
2023 - 07 - 26
6
2023 - 05 - 19
6
2023 - 05 - 15
6
2023 - 04 - 13
5
2023 - 04 - 12
6
2023 - 04 - 11
5
2023 - 02 - 13
5
2023 - 01 - 24
5
2022 - 12 - 06
4
2022 - 11 - 23
4
2022 - 10 - 20
4
2022 - 09 - 29
4
2022 - 09 - 26
4
2022 - 09 - 19
5
2022 - 08 - 17
4
2022 - 08 - 02
4
2022 - 06 - 17
5
2022 - 05 - 16
4
2022 - 04 - 28
7
2022 - 04 - 13
5
2022 - 04 - 12
4
2022 - 03 - 16
4
2022 - 03 - 10
4
2022 - 03 - 08
4
2022 - 03 - 01
5
2022 - 02 - 17
4
2021 - 12 - 14
4
2021 - 11 - 04
4
2021 - 11 - 01
4
2021 - 10 - 29
4
2021 - 09 - 16
4
2021 - 08 - 18
3
2021 - 08 - 11
3
2021 - 08 - 09
3
2021 - 07 - 29
3
2021 - 07 - 23
3
2021 - 07 - 08
4
2021 - 06 - 29
3
2021 - 06 - 11
4
2021 - 06 - 09
5
2021 - 06 - 04
5
2021 - 06 - 03
3
2021 - 05 - 24
4
2021 - 05 - 12
3
2021 - 05 - 10
3
2021 - 04 - 23
3
2021 - 04 - 07
4
2021 - 04 - 05
3
2021 - 04 - 02
3
Sector
Commercial services
7
Communications
11
Consumer durables
2
Consumer non-durables
12
Distribution services
3
Electronic technology
21
Energy minerals
3
Finance
17
Health care and social assistance
1
Health services
3
Health technology
1030
Industrial services
4
Information
1
Manufacturing
107
Mining, quarrying, and oil and gas extraction
2
N/a
38
Non-energy minerals
4
Process industries
16
Producer manufacturing
21
Professional, scientific, and technical services
6
Real estate and rental and leasing
2
Retail trade
3
Technology services
13
Utilities
3
Tags
Abbvie
78
Active
14
Aesthetic
22
Alliances
19
America
43
Antibody
17
Application
15
Approval
37
Atopic dermatitis
10
Biomidwest
43
Biotech-beach
10
Business
12
Cancer
53
Cd20
13
Clinical-trials-phase-iii
26
Collaboration
23
Conference
32
Contract
13
Deadline
11
Dermatitis
14
Disease
65
Drug
75
Duobody
13
Earnings
22
Europe
16
Events
24
Expected
18
Eye
17
Fda
42
Financial
26
Financial results
12
Genetown
11
Global
113
Growing
24
Growth
174
Health
20
Key
12
Leukemia
16
Market
388
Meeting
13
Migraine
23
N/a
789
Pharma
18
Pharmaceuticals
11
Phase 3
30
Positive
31
Reach
16
Report
97
Research
81
Results
80
Rinvoq
28
Risankizumab
14
Set
20
Skyrizi
16
Therapeutics
88
Therapy
40
Treatment
117
Trial
32
Ulcerative colitis
14
Year
12
Entities
Abbott laboratories
61
Abbvie inc.
1030
Adc therapeutics sa
9
Agios pharmaceuticals, inc.
12
Albemarle corporation
7
Alcon inc.
15
Alkermes plc
8
Alnylam pharmaceuticals, inc.
12
Amgen inc.
167
Anika therapeutics inc.
10
Astellas pharma inc
49
Astrazeneca plc
100
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
58
Baxter international inc.
28
Becton, dickinson and company
7
Beigene, ltd.
11
Biocryst pharmaceuticals, inc.
13
Biogen inc.
37
Biomarin pharmaceutical inc.
8
Blueprint medicines corporation
11
Boston scientific corporation
9
Bristol-myers squibb company
88
Catalent, inc.
7
Clovis oncology, inc.
10
Coherus biosciences, inc.
39
Csl ltd
9
Eli lilly and company
111
Endo international plc
11
Epizyme, inc.
10
Exelixis, inc.
11
Genmab a/s
30
Gilead sciences, inc.
41
Glaxosmithkline plc
156
Grifols sa
10
Illumina, inc.
11
Incyte corporation
17
Ironwood pharmaceuticals, inc.
13
Johnson & johnson
162
Karyopharm therapeutics inc.
13
Medtronic plc
20
Novartis ag
239
Novo nordisk a/s
14
Omeros corporation
13
Orange
9
Otonomy, inc.
13
Pfizer, inc.
37
Regeneron pharmaceuticals, inc.
23
Rigel pharmaceuticals, inc.
10
Sanofi
211
Takeda pharmaceutical company limited
31
Terumo corp
8
Teva pharmaceutical industries limited
10
Teva pharmaceutical industries ltd
130
Thermo fisher scientific inc
33
Ucb s.a.
14
Verastem, inc.
10
Viatris inc.
69
Xeris pharmaceuticals, inc.
11
Y-mabs therapeutics, inc.
10
Symbols
AAPL
1198
ABB
1433
ABBV
1030
ABLZF
1172
ABT
1797
ACN
602
AMGN
744
ARVL
4319
AVGO
597
AZN
668
BDX
796
BMY
662
BNPQF
1768
BNPQY
1768
CSCO
900
DHR
786
ERIC
1617
F
643
FNCTF
7229
FRBA
602
GE
919
GLAXF
661
GOOG
1297
GOOGL
1296
GSK
887
HON
1792
HUBS
1400
IBM
657
INTC
955
IT
595
JNJ
4606
LLY
1711
LTUM
973
LYV
717
MDT
1286
MMM
938
MS
4298
MSFT
1205
MT
592
NOK
917
NOKBF
993
NVO
636
NVS
1245
NVSEF
1035
ORCL
1161
PCRFF
651
PCRFY
651
PFE
693
PHG
963
PPRUF
1131
PPRUY
1132
SAP
1481
SAPGF
1235
SNOW
796
SNY
4559
SNYNF
3617
TEVJF
633
TMO
1630
VZ
1223
XYF
678
Exchanges
Amex
2
Nasdaq
613
Nyse
1030
Crawled Date
2024 - 04 - 22
5
2024 - 03 - 22
6
2024 - 02 - 28
5
2024 - 02 - 15
4
2024 - 02 - 12
4
2024 - 02 - 02
4
2023 - 12 - 12
4
2023 - 12 - 05
4
2023 - 11 - 01
4
2023 - 09 - 18
5
2023 - 07 - 27
6
2023 - 07 - 26
6
2023 - 05 - 19
5
2023 - 05 - 15
6
2023 - 04 - 13
5
2023 - 04 - 12
6
2023 - 04 - 11
5
2023 - 02 - 13
4
2023 - 01 - 24
5
2023 - 01 - 10
4
2022 - 12 - 15
4
2022 - 12 - 06
4
2022 - 11 - 23
4
2022 - 10 - 20
4
2022 - 09 - 27
4
2022 - 09 - 19
5
2022 - 08 - 17
4
2022 - 08 - 02
5
2022 - 06 - 17
5
2022 - 05 - 16
4
2022 - 04 - 28
7
2022 - 04 - 13
5
2022 - 04 - 12
4
2022 - 04 - 08
4
2022 - 03 - 16
4
2022 - 03 - 08
4
2022 - 03 - 01
4
2022 - 02 - 17
4
2021 - 11 - 01
4
2021 - 10 - 29
4
2021 - 09 - 16
4
2021 - 09 - 03
3
2021 - 08 - 18
3
2021 - 08 - 11
3
2021 - 08 - 09
3
2021 - 07 - 29
3
2021 - 07 - 27
3
2021 - 07 - 08
4
2021 - 06 - 29
3
2021 - 06 - 11
4
2021 - 06 - 09
5
2021 - 06 - 04
5
2021 - 06 - 03
3
2021 - 05 - 24
3
2021 - 05 - 12
3
2021 - 05 - 10
3
2021 - 04 - 23
3
2021 - 04 - 07
4
2021 - 04 - 05
3
2021 - 04 - 02
3
Crawled Time
00:00
41
00:20
6
01:00
32
01:10
1
02:00
23
03:00
24
04:00
18
04:20
7
05:00
12
06:00
20
07:00
25
08:00
24
08:20
1
09:00
23
10:00
16
10:10
1
10:51
1
11:00
42
12:00
58
12:15
10
12:20
15
12:30
6
12:34
1
13:00
59
13:07
3
13:13
1
13:15
10
13:17
1
13:20
12
13:27
1
13:30
17
13:50
1
14:00
53
14:03
1
14:04
1
14:07
1
14:12
1
14:15
7
14:20
10
14:30
12
15:00
50
15:11
1
15:15
7
15:20
10
15:30
16
15:49
1
16:00
49
16:20
7
17:00
38
17:37
1
17:43
1
18:00
39
18:04
1
18:31
2
19:00
32
20:00
49
20:20
7
21:00
27
22:00
37
23:00
50
Source
beamforall.com
1
investor.assemblybio.com
2
www.biospace.com
241
www.fda.gov
24
www.globenewswire.com
76
www.jupiterwellnessinc.com
1
www.prnewswire.com
684
www.vermillion.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Abbv
save search
AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation
Published:
2021-02-19
(Crawled : 17:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
59.85%
|
O:
0.16%
H:
0.44%
C:
-1.15%
EOLS
|
$11.48
-1.88%
-1.92%
260K
|
Health Technology
|
63.41%
|
O:
48.18%
H:
39.59%
C:
15.83%
Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
Published:
2021-08-19
(Crawled : 02:00)
- globenewswire.com
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
44.55%
|
O:
-0.92%
H:
2.37%
C:
1.48%
CHRS
|
$2.03
-6.88%
-7.39%
720K
|
Health Technology
|
-84.58%
|
O:
1.27%
H:
8.73%
C:
1.47%
treatment
lung cancer
positive
therapy
results
cancer
phase 3
trial
Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. to Board of Directors
Published:
2021-06-28
(Crawled : 16:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
50.06%
|
O:
0.25%
H:
0.75%
C:
-0.23%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-4.55%
|
O:
0.24%
H:
2.98%
C:
2.4%
CABA
|
$12.94
-2.85%
-2.94%
930K
|
Health Technology
|
78.07%
|
O:
1.87%
H:
8.33%
C:
6.04%
biopharma
Uveitis Drugs Market, High Prevalence Of Eye Disorders And Associated Risk Factors Of Uveitis to Boost Market Growth - Technavio
Published:
2022-08-08
(Crawled : 22:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
15.03%
|
O:
1.28%
H:
0.8%
C:
0.13%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
46.06%
|
O:
-7.02%
H:
7.55%
C:
-4.6%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
20.81%
|
O:
0.24%
H:
1.11%
C:
-0.31%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-11.21%
|
O:
-0.56%
H:
1.04%
C:
0.58%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
10.62%
|
O:
-0.03%
H:
1.02%
C:
0.47%
risk
eye
growth
market
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
Published:
2024-02-15
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-2.11%
|
O:
0.48%
H:
1.56%
C:
1.48%
IRWD
|
$8.11
-2.41%
-2.47%
1.9M
|
Health Technology
|
-46.21%
|
O:
-5.63%
H:
7.34%
C:
2.81%
year
pharmaceuticals
ironwood
financial
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-25
(Crawled : 15:49)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-26.09%
|
O:
0.11%
H:
0.39%
C:
0.06%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
310.2%
|
O:
0.46%
H:
1.46%
C:
1.15%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-21.36%
|
O:
1.12%
H:
0.0%
C:
-0.33%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
64.51%
|
O:
-0.16%
H:
1.21%
C:
0.95%
SUPN
|
$30.26
1.04%
1.02%
200K
|
Health Technology
|
19.09%
|
O:
-0.32%
H:
5.23%
C:
4.43%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-3.07%
|
O:
0.89%
H:
0.5%
C:
0.41%
OTIC
|
$0.077
|
Health Technology
|
-97.09%
|
O:
-1.88%
H:
2.3%
C:
0.0%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-84.11%
|
O:
-1.44%
H:
3.5%
C:
2.24%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
4.16%
|
O:
0.67%
H:
0.15%
C:
-1.22%
BMRN
|
$91.25
-0.88%
-0.89%
1.6M
|
Health Technology
|
23.19%
|
O:
-0.72%
H:
1.06%
C:
0.76%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-58.4%
|
O:
-4.08%
H:
7.03%
C:
6.04%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
11.44%
|
O:
0.64%
H:
0.2%
C:
-0.32%
Vitiligo Therapeutics Market - Information on Key Vendors Including (Alkem Laboratories Ltd., Bausch Health Companies Inc., Canixa Life Sciences, and more)
Published:
2022-08-25
(Crawled : 11:00)
- prnewswire.com
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
23.82%
|
O:
0.0%
H:
0.0%
C:
0.0%
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-34.75%
|
O:
1.55%
H:
0.1%
C:
0.1%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-34.1%
|
O:
1.04%
H:
0.62%
C:
0.34%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
11.81%
|
O:
0.0%
H:
0.49%
C:
0.1%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
-30.13%
|
O:
0.55%
H:
1.56%
C:
1.51%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
61.86%
|
O:
0.95%
H:
6.02%
C:
3.95%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
22.94%
|
O:
0.62%
H:
0.57%
C:
0.4%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
11.88%
|
O:
0.62%
H:
0.02%
C:
-0.13%
companies
health
life
therapeutics
market
Aspira Women’s Health Announces Fourth Quarter Operational Metrics and Provides Updates on Its OvaWatch and EndoCheck Programs
Published:
2022-01-05
(Crawled : 12:30)
- vermillion.com
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
25.25%
|
O:
-0.01%
H:
0.0%
C:
0.0%
AWH
|
$3.35
-1.18%
-1.19%
4.5K
|
Health Technology
|
98.25%
|
O:
2.34%
H:
5.71%
C:
-8.57%
health
women
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published:
2023-11-01
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-21.94%
|
O:
-1.46%
H:
3.67%
C:
3.26%
ZYME
|
$8.555
-0.06%
-0.06%
590K
|
Health Technology
|
21.94%
|
O:
1.14%
H:
0.42%
C:
-0.7%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-2.23%
|
O:
1.03%
H:
0.73%
C:
0.58%
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
640.58%
|
O:
-0.16%
H:
6.42%
C:
4.49%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
19.0%
|
O:
-0.86%
H:
0.0%
C:
0.0%
STRO
|
$3.47
-6.72%
-7.2%
540K
|
Health Technology
|
44.19%
|
O:
0.39%
H:
3.86%
C:
3.86%
IMGN
|
News
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-16.41%
|
O:
-0.47%
H:
1.88%
C:
1.78%
EXEL
|
$23.7
1.76%
1.73%
1.5M
|
Health Technology
|
10.8%
|
O:
-2.62%
H:
1.17%
C:
-1.66%
drug
antibody
breast
cancer
treatment
global
market
Infinity Pharmaceuticals Reports Full Year 2022 Financial Results
Published:
2023-03-28
(Crawled : 21:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
7.62%
|
O:
0.17%
H:
0.51%
C:
0.29%
MEIP
|
$3.26
-2.17%
-2.22%
7.4K
|
Health Technology
|
-30.62%
|
O:
0.42%
H:
1.49%
C:
-5.73%
INFI
|
$0.016
12.5%
1.1M
|
Health Technology
|
-91.26%
|
O:
5.74%
H:
5.43%
C:
-0.52%
year
pharmaceuticals
financial
results
Global $500+ Mn Neurotrophic Keratitis Markets, 2023-2028: Empowering Vision Health - Neurotrophic Keratitis Market on the Rise
Published:
2023-08-25
(Crawled : 17:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-1.96%
|
O:
0.67%
H:
0.37%
C:
0.26%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-8.75%
|
O:
0.51%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
15.2%
|
O:
-0.11%
H:
0.44%
C:
-0.22%
KALA
|
$6.5661
4.24%
1.1K
|
Health Technology
|
-52.01%
|
O:
-1.31%
H:
0.85%
C:
0.67%
BBIO
|
$25.02
-1.73%
-1.76%
1.5M
|
Health Technology
|
-9.33%
|
O:
0.71%
H:
5.34%
C:
4.95%
health
global
market
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-21
(Crawled : 00:00)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-32.18%
|
O:
0.18%
H:
1.54%
C:
1.39%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
238.16%
|
O:
0.25%
H:
2.13%
C:
1.63%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-26.3%
|
O:
0.21%
H:
0.83%
C:
0.33%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
49.88%
|
O:
0.5%
H:
1.37%
C:
0.91%
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
-56.69%
|
O:
0.24%
H:
0.73%
C:
-4.13%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-10.97%
|
O:
-0.32%
H:
0.17%
C:
-0.13%
OTIC
|
$0.077
|
Health Technology
|
-96.58%
|
O:
0.0%
H:
3.98%
C:
-1.33%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-79.48%
|
O:
1.39%
H:
0.79%
C:
0.33%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
0.63%
|
O:
0.57%
H:
0.86%
C:
0.54%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-72.44%
|
O:
0.5%
H:
4.88%
C:
4.7%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
14.61%
|
O:
0.4%
H:
0.53%
C:
0.25%
AbbVie and REGENXBIO Announce Eye Care Collaboration
Published:
2021-09-13
(Crawled : 11:00)
- prnewswire.com
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
58.92%
|
O:
0.67%
H:
1.29%
C:
0.08%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-51.93%
|
O:
21.86%
H:
9.05%
C:
7.66%
CLSD
|
News
P
|
$1.33
-2.92%
-3.01%
200K
|
Health Technology
|
-79.24%
|
O:
0.3%
H:
4.82%
C:
2.72%
eye
collaboration
AbbVie Reports Second-Quarter 2023 Financial Results
Published:
2023-07-27
(Crawled : 15:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
19.85%
|
O:
2.13%
H:
4.77%
C:
3.02%
abbvie
financial
results
Hyperhidrosis Treatment Market to Reach USD 950.7 Million, Globally, by 2031 at 5.1% CAGR: Allied Market Research
Published:
2022-10-13
(Crawled : 12:00)
- prnewswire.com
ROIV
|
$10.89
-0.46%
-0.46%
2.8M
|
Manufacturing
|
147.51%
|
O:
-2.94%
H:
7.46%
C:
7.23%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
127.7%
|
O:
-1.68%
H:
4.47%
C:
4.07%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
21.12%
|
O:
-2.34%
H:
4.74%
C:
4.55%
treatment
research
market
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
Published:
2023-01-06
(Crawled : 13:20)
- prnewswire.com
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
3.7%
|
O:
0.83%
H:
1.98%
C:
1.04%
IMNM
|
$14.28
-2.59%
-2.66%
560K
|
Health Technology
|
211.25%
|
O:
21.66%
H:
4.71%
C:
-17.63%
collaboration
Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
Published:
2022-01-10
(Crawled : 13:30)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
25.39%
|
O:
-0.37%
H:
0.0%
C:
0.0%
IRWD
|
$8.11
-2.41%
-2.47%
1.9M
|
Health Technology
|
-29.93%
|
O:
-3.79%
H:
4.65%
C:
4.29%
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-04-13
(Crawled : 18:40)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-29.17%
|
O:
0.03%
H:
0.56%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
304.89%
|
O:
0.03%
H:
1.03%
C:
0.22%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-22.95%
|
O:
0.27%
H:
0.33%
C:
0.09%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
56.66%
|
O:
-1.85%
H:
0.42%
C:
-0.3%
YMAB
|
$15.26
-0.52%
-0.52%
160K
|
Health Technology
|
-40.03%
|
O:
0.55%
H:
5.75%
C:
4.16%
VSTM
|
$9.29
-3.33%
-3.44%
79K
|
Health Technology
|
255.93%
|
O:
-1.85%
H:
2.64%
C:
1.13%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-6.18%
|
O:
0.56%
H:
0.18%
C:
-0.4%
RIGL
|
$1.125
-1.32%
-1.33%
6.4M
|
Health Technology
|
-68.42%
|
O:
-1.66%
H:
9.58%
C:
5.07%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
90.2%
|
O:
0.2%
H:
1.83%
C:
0.66%
KPTI
|
$1.1
0.92%
0.91%
1.2M
|
Health Technology
|
-89.21%
|
O:
0.89%
H:
5.1%
C:
0.1%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-35.96%
|
O:
0.0%
H:
3.18%
C:
1.93%
ILMN
|
$122.74
-1.38%
-1.4%
1.2M
|
Health Technology
|
-69.13%
|
O:
0.87%
H:
0.47%
C:
-2.11%
EXEL
|
$23.7
1.76%
1.73%
1.5M
|
Health Technology
|
-0.56%
|
O:
-0.38%
H:
4.2%
C:
3.09%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-82.04%
|
O:
0.18%
H:
3.17%
C:
0.24%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.6%
|
O:
0.0%
H:
4.56%
C:
1.79%
BPMC
|
$92.31
0.02%
0.02%
560K
|
Health Technology
|
-0.85%
|
O:
0.37%
H:
6.32%
C:
3.68%
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-53.72%
|
O:
0.24%
H:
2.16%
C:
-0.12%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
132.12%
|
O:
0.15%
H:
2.63%
C:
-0.15%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
9.44%
|
O:
0.01%
H:
0.61%
C:
-0.14%
ALNY
|
$143.8
-1.55%
-1.58%
390K
|
Health Technology
|
7.22%
|
O:
0.86%
H:
2.16%
C:
0.66%
AGIO
|
$31.67
-0.44%
-0.44%
540K
|
Health Technology
|
-38.9%
|
O:
0.73%
H:
4.5%
C:
1.75%
cancer
approval
Coherus Announces Positive Results of UDENYCA® On-Body Injector Clinical Trial
Published:
2021-10-05
(Crawled : 13:15)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
55.93%
|
O:
0.61%
H:
1.09%
C:
0.11%
CHRS
|
$2.03
-6.88%
-7.39%
720K
|
Health Technology
|
-86.21%
|
O:
0.25%
H:
4.54%
C:
2.02%
positive results
positive
results
trial
AbbVie Seeks New Indication for Migraine Drug Qulipta, Drops Deal with Morphic
Published:
2022-06-22
(Crawled : 16:00)
- biospace.com/
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
21.18%
|
O:
2.73%
H:
4.44%
C:
2.67%
drug
deal
migraine
← Previous
1
2
3
4
5
6
7
8
9
…
51
52
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.